Page 5 - Prime Editor News Today

OUP Management Co. LLC bought a new position in Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 121,255 shares of the company’s stock, valued at approximately $2,253,000. Prime Medicine makes up about 3.7% of […]

Prime Medicine’s (NYSEARCA:PRME – Get Rating) lock-up period will end on Tuesday, April 18th. Prime Medicine had issued 10,294,118 shares in its IPO on October 20th. The total size of the offering was $175,000,006 based on an initial share price of $17.00. Shares of the company owned by company insiders and major shareholders will be […]

Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) shares gapped up prior to trading on Tuesday . The stock had previously closed at $13.33, but opened at $13.92. Prime Medicine shares last traded at $13.49, with a volume of 9,634 shares changing hands. Wall Street Analysts Forecast Growth Several equities analysts have commented on PRME shares. […]

Research analysts at Stifel Nicolaus assumed coverage on shares of Prime Medicine (NYSEARCA:PRME – Get Rating) in a note issued to investors on Monday, The Fly reports. The brokerage set a “buy” rating on the stock. Separately, Morgan Stanley reduced their price objective on Prime Medicine from $23.00 to $21.00 and set an “equal weight” […]

Should You Buy or Sell Prime Medicine Stock? Get The Latest PRME Stock Forecast, Price Target, Headlines, Short Interest at MarketBeat.

Nowadays, investors keep a close watch on potential short squeezes, as several short squeezes in the recent past have helped many generate outsized returns. Potential short candidates Prime Medicine (PRME),...

Shares of Prime Medicine, Inc. (NYSEARCA:PRME – Get Rating) traded down 5.3% during trading on Wednesday . The stock traded as low as $12.50 and last traded at $12.57. 34,582 shares traded hands during trading, a decline of 78% from the average session volume of 158,016 shares. The stock had previously closed at $13.28. Wall […]

Conservation. it will end up at the un in lisbon. i conservation. it will end up at the un in lisbon-— conservation. it will end up at the un in lisbon. i imagine most of the messaue un in lisbon. i imagine most of the message and _ un in lisbon. i imagine most of the message and send _ un in lisbon. i imagine most of the message and send that _ un in lisbon. i imagine most of the message and send that to - un in lisbon. i imagine most of the message and send that to buy - un in lisbon. i imag...

The new technique in a lab to fix genes that cause to diseases including sickle cell anemia. the breakthrough builds on an existing method to edit dna called chris burke. except researcher will say that it is a lot more precise. jonathan reporting with more on this. >> very exciting, it is called prime editing, and it may offer a more precise way of correcting dna than current methods. instead of cutting both strands of dna at the same time like a scissors, the prime editor nips one side and ins...